NCT02742909View on ClinicalTrials.gov

Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Pulmonary Hypertension
Interventions
DRUG

rhBNP

rhBNP was administered as a continuous infusion for 24 hours before or after placebo

DRUG

placebo

normal saline as a placebo was administered as a continuous infusion for 24 hours

Trial Locations (1)

110004

Shenjing Hospital, Shenyang

All Listed Sponsors
lead

LI ZHAO

OTHER

NCT02742909 - Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease | Biotech Hunter | Biotech Hunter